Reaction
Joint Laxity reporting signals
As of the last recalculation, Joint Laxity appears in 299 FAERS reports alongside 15 co-occurring drug terms. The strongest observed disproportionality signal is NAPROXEN SODIUM TABLET, COATED (PRR 443.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Naproxen Sodium Tablet, Coated | 67 | 443.6 | 445.8 |
| Naproxen Sodium, Coated Tablets | 67 | 443.6 | 445.8 |
| Naproxen Sodium 220Mg | 67 | 443.0 | 445.2 |
| Valproate Sodium | 53 | 216.7 | 217.3 |
| Hydroxychloroquine | 102 | 143.8 | 144.0 |
| Tocilizumab | 131 | 141.5 | 141.6 |
| Leflunomide | 123 | 138.3 | 138.5 |
| Abatacept | 129 | 113.3 | 113.4 |
| Hydroxychloroquine Sulfate | 98 | 110.9 | 111.0 |
| Acetaminophen And Codeine | 17 | 102.9 | 103.1 |
| Naproxen | 67 | 76.2 | 76.3 |
| Naproxen Sodium | 103 | 76.0 | 76.1 |
| Tofacitinib | 116 | 70.9 | 70.9 |
| Naproxen Sodium Tablet | 36 | 53.6 | 53.6 |
| Desoximetasone | 10 | 37.8 | 37.8 |